Jet Lag Therapy Treatment Market Growth, Size, Application 2019 | Clinigen Group plc, Vanda Pharmaceuticals, Pfizer Inc, Jamieson Laboratories Ltd., NOW Foods, Nature’s Bounty, ALEXZA

This newly released Global Jet Lag Therapy Treatment Market research report offers a far reaching examination of the Global Jet Lag Therapy Treatment Market. The report proposes a concise appraisal of the business' set-up through an essential outline. The report covers a detailed depiction of Jet Lag Therapy Treatment Market, its vital applications, and the creation innovation that is used. It likewise comprehends the focused situation, current patterns in the business, and generous regional standing. The investigation of the market has been coordinated by assessing 2019 as the base year and the figure time frame extends over till 2026.

In this Jet Lag Therapy Treatment Market report a wide scope of research tools and techniques has been utilized to get an understanding into the competitive scene by analyzing different market segments and the significant market players.

Get Sample Copy of This Research Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-jet-lag-therapy-treatment-market

Global jet lag therapy treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global jet lag therapy treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Among the largest key players competing in this market include Clinigen Group plc, Vanda Pharmaceuticals, Pfizer Inc, Jamieson Laboratories Ltd., NOW Foods, Nature’s Bounty, ALEXZA, Jazz Pharmaceuticals, Inc, Eisai Co., Ltd, Purdue Pharma L.P. and others.

Segmentation: Global Jet Lag Therapy Treatment Market

By Application - Business Travelers, Cabin Crew, Athletes, Seasonal Travelers and Others

By Treatment Type - Sunlight, Bright Light Therapy, Melatonin Supplements, Sleeping Pills, Exercise and Others

By Drugs - Nonbenzodiazepines, Benzodiazepines and Others

By Route of Administration - Oral and Injectable

By End-Users – Hospitals, Homecare, Specialty Clinics, Others

By Geography - North America, South America, Europe, Asia-Pacific, Middle East and Africa

Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-jet-lag-therapy-treatment-market

Market Drivers

• Exposure to high altitudes and cabin pressures associated with air travel act as drivers to the market growth
• Changes in the working shift timings associated with night shifts is also expected to drive this market growth
• New launches of insomnia related products annually can boost the market growth
• Rise in number of travelers who are traveling to different time zones is propelling the market growth

Market Restraints

• Preference of non-pharmacological therapies over pharmacological therapies are hindering the market growth
• Introduction of alternative therapy to beat the jet lag disorders is restraining the market growth
• Limited efficacy rate of available intervention is expected to restrain the growth of the market

Key Developments in the Market:

In June 2019, Clinigen Group plc received marketing authorization for Melatonin oral solution and Melatonin film coated tablet from the Medicines and Healthcare products Regulatory Agency both forms are used for the treatment of short-term treatment of jet-lag in adults. This approval will ensure efficacy and reliable treatment for patients experiencing jet lag

In December 2018, Vanda Pharmaceuticals Inc received the FDA’s acceptance for supplemental New Drug Application (sNDA) for Hetlioz (tasimelteon), melatonin receptor agonist for the treatment of jet lag disorders. It has been already approved for Non-24-Hour Sleep-Wake Disorder. If approved, it will be beneficial for those whose sleep pattern interrupted by a jet lag

Reasons to Purchase this Report

• Current and future of global jet lag therapy treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

View Detailed Table of Content @ https://databridgemarketresearch.com/toc/?dbmr=global-jet-lag-therapy-treatment-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.